Experimental Analysis of the Efficacy of Dihydroquercetin on the Model of Chronic Nonbacterial Inflammation of the Prostatic Gland


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We studied the efficiency of dihydroquercetin on the model of chronic nonbacterial inflammation of the prostatic gland in rats. It was found that administration of dihydroquercetin was followed by a significant decrease in the area of the connective tissue in the prostatic gland to initial levels, which attested to antifibrotic properties of this oxidant. Additionally, the substance prevented the development of atrophy of acinus epithelium. After administration of reference drug Prostamol Uno, only moderate antifibrotic effects were observed.

Sobre autores

T. Borovskaya

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences

Autor responsável pela correspondência
Email: repropharm@yandex.ru
Rússia, Moscow

S. Kamalova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Moscow

M. Polyektova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Moscow

V. Mashanova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Moscow

A. Vychuzhanina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Moscow

S. Kseneva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Moscow

M. Plotnikov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences

Email: repropharm@yandex.ru
Rússia, Moscow

V. Goldberg

Tomsk Research Institute of Oncology, Tomsk National Medical Research Center

Email: repropharm@yandex.ru
Rússia, Tomsk


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies